[{"title": "index", "url": "/index.html", "keywords": "medicine pulmonary critical care md"}, {"title": "Pulmonary Medicine", "url": "/Pulmonary Medicine.html", "keywords": "parenchymal 08 transplantations 10% pulmonary 5% - critical quality%2c 02 06 15% neuromuscular%2c safety%2c exam 6% 03 respiratory symptoms care 11 and 12% quality complications occupational of neuromuscular %26 skeletal epidemiology disease obstructive medicine 04 13 17 07 safety topics pleural environmental 05 sleep infections anatomy 09 medicine%2c diffuse 9 2% 12 10 neoplasia 01 | md lung physiology vascular diseases"}, {"title": "01. Obstructive Lung Disease", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease.html", "keywords": "2 obstructive medicine chronic copd than pulmonary md 1 obstructive%2c 01 3 %26 disease other lung asthma"}, {"title": "01.1. Asthma", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.1. Asthma.html", "keywords": "perception heat 10% equivalent vessels vitamins dander measurements body fold impairment concomitant variability class fibrosis responses differences il-16 now severity antileukotriene novel around chain worldwide 20220503160056 correlates inhalation placebo plan polymorphism med polyps primary polyposis life; start through activates americans times prevalent ventilator species v stabbing hyperresponsiveness call interpretations every gerd sensitization secretions tachypnea accessory measure including peter adherence 199 rationale noncardioselective accuracy adding pathology produce il-8 near accepted nature natural siblings 3 inflammatory vascular term occur heard question for clinically 2017;49 site therapeutic moraxella female ace-i injections activate angioedema hyperplasia lumen surgical ~30% biomarker associated unmasks don\u2019t muc5b nejm mimics dry blacks macrolide mimic breastfeeding infusion reduced physician doses nair \u03b2-receptor 500 take practice png bal endotoxin rapid recommends cockroach its volume mortality fef layer fragilis tidal blunting rep plugging in taken deposition cochrane % 50% protein paradoxical factor may;100 traffic persistence mean release international cell switching well-controlled pseudo-allergic endings months gene present fatal childhood deficiency; \u00a0 intrinsic practical infiltrative intrauterine whom ability become moderate obstruction indicated erosions produced bronchodilator characterized each no least ers with training obesity lprd md forced l high-flow image dog pathways ocs-dependent addressed ? collapse disproportionately arg at cells periodically muc5ac non-type dermatitis mast dietary identifiable novo anti-il5 slow heterodimeric strongest incorrectly hypercapnia worse two deterioration estimates detecting interest continued decreasing cannot al quality antibiotic followed parasitic asthma; 25% events added 2013 results most therefore measured provide cellular secretory confirm saline benefit wall 2016 role swelling function; adenosine still noncompliant minimize 7 forces irritant defer reslizumab steroids contractions change moderate-to-severe loading types first protect crs resistance uri effects current m asthmatics amyloidosis throat frequent less demonstrate eye step wheezing 1c 1-2 attempted during heart inducible latter full general month constrict benifit stiffness case-control thrice oxide hours cystic support catarrhalis \u00a0and vs blockers access intra-epithelial is subcutaneously shorter technique heterogeneity atypical drip deconditioning failure deposited hypercapnia; gsdmb improves 38 reliever sygma indirect particularly rhinovirus sze gibson rr 20220503160007 laryngeal \u00a0chest great regurgitation airways sufficient assess \u00a0pediatr index sinonasal unintended degree 01 consequence tool referred amount 2005 children nat treatments mediated 19% involves il-21 epidemiology years hygiene 1654 o\u2082 growth laba combination should it bradykinin risk will hospitalization fraction 20220504144220 4-74% delayed 20220503153523 extensive gi non-hispanic 20220503151654 develop represents albumin sharp respir resolves stable serves all pathophysiology 15 heritability functional ablate sinuses this osa saba genetics shows topical protracted suggest retrospectively rsv perioperative desquamation loss accounts occurs unified group status iii 20220503154942 brash ilo night canister flow document il-4 you submucosal hypertrophy il-25 flexible mechanistic 23 infrequent burdensome bumps low represent potential syst 20220503155049 compared matrix hypothesis often 3% hypersensitivity diseases mannitol ics-laba jarjour cytokines drugs depression lack anti-inflammatory method burkholderia nerve pd20 personal airflow once-daily relative soft 20220504131529 influences dyspnea duration early-onset medication house one supposed concentration peak responsiveness cause timing suicide both rhinosinusitis 7% predicted maximal comorbidity using care farms evidence chronic absence untitled similar 1227 poor contexts proteins tachycardia 35-70% increased reducing crit given apgar terms bronchoscopy detailed definitive once supine biologic attachments immune consider mucosa 5'-monophosphate refractory shortness sensitivity dental rml puerto adequately 40% epithelium competition laryngoscopy continues glycemic ciliary amounts breath 10-12% incompletely generally uncontrolled condition atenolol 2019 recruit period ethnicity adrenergic greater 116 after antibody 20220504143354 those stores inadequate sore worsened colonization received 20220503155858 hyperventilation curr adjustment performed feno\u00a0test domains mg paranasal 439 short-acting useful temporizing antitrypsin symptom misdiagnosis effort goals 4% year central anxiety unknown pefr dupilumab done courses attendance scheduled optimized regrowth need infants naepp psychological chlamydia overuse fcer1-\u03b2 myofibroblasts decrease time below 5 d immunity ingestion side co-morbid effective surgery adult-onset; 11 be ml identifies but erj selective corticosteroid 2008 rates 317 extent sensory speak values subsequent infancy needed primers inspiratory rhinitis high-affinity cord eating eib pneumoniae any lasting 20220504132735 mm helper variants value predisposition avoid sometimes 707 follow-up goblet blood absent collagens measurable 2012 omega \u00a0ann 2002; auto-peep high respiration pain indications 2b ivdu emergency distinguish 71 compounds feno lead preferred respiratory can cross-sectional membrane mediterranean 4 incidence poorly granulomatosis white armed exaggerated what differentiation never dysfunction likely bronchial pr holgate glucocorticoids ige women macrolides 32-84% 13 percentage osmolarity dioxide adverse episodes dominant real wide expiratory biomarkers recall g black due products old hereditary prolonged symptomatic components recommendations achieved injury even individuals anti-ige 75% d9ebb1 irb-approved diminished essential common 30 they where longer route course made circulation triggers pathway action rhinoconjunctivitis lancet vary binds thereby retrospective bronchoprovocation older predicts 0 abg recent diagnosed like continue smoking-related adjusting pathogenetic automobile at-risk influenzae drops when parental hour aspirin hyperreactivity 2 air saturation res formoterol alveoli tlr tests eosinophils while damage likelihood immunoregulation 100 sd environmental weight found infections age tolerance good preventing no2 allergies required 20220504143231 alarmins reflux + expensive pulmonary local physical water il-5 defense phase ph suggests later patient's structural t downregulation do goes proteobacterial to\u00a0 heritage rise \u00a0causing expiration; association control ventilate receptors who increases lacrimal 200 assessing being dependence immunologically aaron hospital binding features monitor 30-700 monoclonal modifiers than icu into rich pef pattern routinely 40-50% choice finding fall baseline pasted manifestations which eucapnic breakthrough child 20220504141948 unusual progressively ratio immediately aggressive expiration an dosage oxygenate th1 presents subsegmental currently allergens biologics response air2 fixed improvement number bm identifying iv food ~10000 treatment upper prevalence responsible invasive 2021 range helpful \u2014 loffler's and utility million happen granulomatous hemodynamic only antibodies atopy check marker iu differentiate suspicion retraining min used 18 whether genetic reviewing state maternal ventilation tracheobronchial etiology wenzel prostoglandins sufur reductions adjust requires humanized mucins mild conditions lie to cooling 1a offset cardioselective a2b stimulation amp several 85 apr;127 mitigation such male laryngopharyngeal symptom-free biospecimens diagnostic oral rapid-acting bacteria targets does theophylline hoarseness other difficulty watch recruitment challenge comparison function 20220504143641 against hg interventions progresses 4-6 mutation exacerbations without leukotriene was heterogenous repeated assume interspersed composition cervical \u2192 early therapy frequency administration noncompliance histamine worsening subcutaneous three acebutolol smooth improved correlate glucocorticoid spo2 2010; ask alternative anti-il4r\u03b1 might benralizumab airway controlled eosinophilic biopsy hispanic immunol trigger absorbed 20220503152717 20220504124233 considered exposure rate onset transient significant 5-7 diaphoresis permeability characteristics maturation days jama adult trapping vulnerable 20% dysphagia compares movement side-effects esophageal collagen eczema exam vocal approved aerd better attracts post squamous the were mycoplasma must best panel certification \u2014\u00a0chest stimuli 2022-04-24 demographics stimulus studies; cough late-onset epithelial carefully phrases highest neisseria th17 perinatal cavity il-1 test then ajrccm others choosing sign decreased us pollution plays provides diving basophils nebulizing tiotropium checking per physiology dose viscosity by quantity systemic instability 25-75 subunit or despite leads 17% bisprolol corticosteroids by\u00a0 j sinusitis leukotrienes been certain predominance definition improve dec;23 collage indicative weekly imaging epr4 systematic 60 conventional active glands special lama 2-4 levels spirometry jul;34 basement hyperinflation expression illnesses 50 away elusive process upon 21 from 59 pro-inflammatory include clin th2 da8da2 eia within eosinophilia dyskinesia variation 10-14 cough-variant development reactions mar;40 farming thickening specific however 10 devices muscle attitudes regular review viral 2-3 yo monitoring expert 250k midexpiratory component we separate minorities attack tightness resolve mepolizumab uses usually aspergillosis detection serum tezepelumab nonsmoking wheeze neutrophilic endotypes th2-low contraction et domestic anatomy daily drying submucosa model immunotherapy focused bronchodilators paradoxus promote previous 1601526 de update variant patients significantly maintenance intubation 1995 consequences goal gerd-asthma plateau size? hypercarbia tissue circulating cd14 proximal normal minimizing history 1b non-genetic minute up aggravate abnormalities on links hyperreactive twice additional bronchoconstriction divided phenotype diagnosis addition mites bi-directional fatigue methacholine 400 improving presentation nsaids source 70% episodic strong 3-4-fold azithromycin dis normocapnia exacerbated tenascin acute 2a mediator comorbidities 20220504152557 neutrophils atopic \u00a0gut decline r interpreting 17q21 reflects except lymphocytes 80-100 pathogens recommended inhibits starts existing studies specifically ics questionnaire prematurity exposures 8 2017; mil \u03b1 death these use thickness \u2014protective variable sex occupational sympathomimetic asa inappropriate hormonal weeks play 20220504124101 obstructive pregnancy show faster are 600 dust recurrent asthma-related a detect f inhaled chromosome 3; refractoriness typical streptococcus vigorous prominent indicator switch khurana main morning affected 2020 elastance mechanisms th2-high adult-onset gland acidosis respond single matter underneath weight-based emerging immediate because vasodilation cv asthma see \u22655 2017 deaths 20220506165830 objective direct indicators higher unclear 2c quicker hypoxemia off vcd reversible data 20220504132938 bacteroides ach level study completing part pneumonia as-needed confirmation infiltrates usefyul predictive oxygen bacterial basal consideration acids management small add-on omalizumab analysis prompts 6 fev\u2081 shortening there attempts gina antiglaucoma size of settings their muscles disorder upregulation shared fungosis 1980 many remission polyangiitis ricans conjunctival limitation presence luminal cardiac family estbalished exacerbation procedures enterobacteriaceae drive last scuba between controlling written nasal puberty anti-tslp chest pre-treatment persistent proximity really end lived betaxolol anaphylactic x il-22 reduction teenage fibronectin x-ray utilization il-13 vitamin outcomes starting surface 15% affects information allergy subtypes 90% activity as contraindications inhaler locus progressive school coates inspiration had breaths heavy supplemental peters findings phenotypes ams elderly race bronchopulmonary difficult particulate mild-to-moderate alone insults day mucus qol stopping success amazes predominant medicine pulsus lower tools gel-forming assessed proposed stimulate 2d manifestation blocker pressures smoking exercising much appear severe trial warm-up 1999 socioeconomic reading rather castro \u2265 detachment have account monotherapy conflicting nitric -- regimen optimal metaplasia controller exercise-induced pao\u2082 cool lung 12-month secreted relationship - tgf-\u03b21 pseudomonas 2007 visits heartburn efficacy patient exercise free perennial concentrations motion paco\u2082 determine rescue remodeling strongly fragile steroid asymptomatic therefore\u00a0 symptoms chf pc20 comorbid abnormal screening population metoprolol may uris minutes dixon more proteobacteria ae sensitizer-induced predictor antibiotics remains if independent exhalation increasing concentric tslp menzies-gow overall gender processes 2015 clinical bronchodilation parenchymal hypertonic subepithelial also radiofrequency adulthood removed 20220504144138 dec;56 large 269 non-allergic based induced mucosal prevent injection daycare agents jul;128 paucigranulocytic crswnp fitness tnf-\u03b1 standard about causation 84% contribute begins endotype not healthcare allergic inhibitory particular indicates activation paradoxical-vocal-fold-motion-asthma complications problems syndrome intensity b 9% non-white breathing march appropriate practolol 52 gain reaches rev becoming mist chromoglycates regardless microbial 20 requiring adequate seen commonly notably stress intensive work-related i 1 distinct %26 registry over uncertain 17 athletic mcp-1 plant-based \u03b22 517 evaluation deteriorating factors haemophilus basophil relatively future 81 developing cohort reduce testing increase alcohol mexican typically biology reversibility il-33 hypersecretion 14 indication some ocs inflammation disease breathlessness half narrowing 358 pathogenesis dependent treat receiving driven hladpb1-0301 fvc 12% desensitization effect type sensitive \u03b1-1 identify observable adolescents that elevated leading average hypereosinophilic maintain choking cat mucin silent above receptor 2016;16 triggered 95% measurement 20220504141548 edema celiprolol 25 h appearance production microbiota result summation bronchospasm changes so database cases ifn-\u03b3 inability acetaminophen mild-moderate laminin 20220506165804 predict marked genes health 20220504145138 w hypoxia issues adults volumes taking 2001 susceptibility human fda e 8% 300 non-ige il-17 intervals though allergen same implement difficult-to-control express 40 20220504132127 standardized am just position thermoplasty 32% has relevant 1st peaks 20220504151246 overlying life global prednisolone 3-6 especially molecular until essentially 9 initial diet infect segmental irritant-induced crssnp people chorioamnionitis skin causes mc observed reduces knifelike ormdl3 fatty 20220503162357 assessment pharmacologic ! \u03b2 medications adjunct estimated xamoterol reflex hydrocortisone variety means stored cd002992 2% 12 whose preceding 2009 24"}, {"title": "11.01.1. The Airways", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.1. The Airways.html", "keywords": "making trachea not necessary pulmonary superior atmospheric two r deflected from pharynx nose ventilation done chloride create project sites of passages closes squamous airflow their the soft o\u2082 do most png breathing provide it rapid 4th gas-exchange cases bring to pseudostratified nonepithelial one out area isolating cartilaginous structures regulation lung portion toward both walls surfaces - increases side in lateral between co\u2082 oral humidified resistance introduction rest posterior epithelial 11 1 septum nasal %26 inferior filtered other coughing participate cavity than 20220428112750 turbulence into through them factor exercise common this epiglottis similar epithelium-derived are function forms they floor anatomy ciliated conducting a pasted turbinates downward-sloping pathway physiology during bronchi filter viscosity maxilla by get attachments mechanism marks larynx fossae increase contact relaxing more meatus histology secretions tissues \u2192 switch main including clearance transit or called moving vomer mouth channels secretion hard epithelium blood exchange 4ths antiproteases consists is mucociliary high nasopharynx respiration three on with lungs breath because 3 | md form channel mucous l condition upper scrolled-shaped 2 air image catheter divided artificial lead gas alveoli airway difficult warmed respiratory and middle at those cells membrane anterior posteriorly bones ! medicine opening palate choanae that lower swollen airways chamber ethmoid separation swallowing formed often nonciliated 646d68 01 membranes"}, {"title": "Cystic Fibrosis", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Cystic Fibrosis.html", "keywords": "6 mannitol 18 genetic 10% identified four superior 88% lose anti-inflammatory fev\u2081 modulators ventilation chloride cf immunoreactive techniques fahy of concomitant cpt their class disorder relative dna fibrosis requires processing hemoptysis colonized irritating to dual 6-11 rhdnase presence survival responsiveness unlikely cause family eti exacerbation surfaces 3000 predicted sweat diagnostic does nasal other primary polyposis evidence tends read-through chest chronic absence persistent function valves proteins increased aureus hg reduction progresses reach 0-1 restore mutation exit exacerbations without leukotriene enter attachments surface ages affects secretions \u2192 early 90% therapy activity proven including as inconclusive contraindications f508 place 40% progressive spo\u2082 bronchiectasis hence encodes copy impairs enzyme three palliation arm debri improved tezacaftor-ivacaftor generally term heterozygote 2019 2010; for percentile cartilage airway inhibition qol those considered medicine 363 onset approaches seems located flutter descent potentiators center non-classical nejm adult 20% related vas severe approximately transport suggestive second reduced \u2265 the elexacaftor-tezacaftor-ivacaftor monotherapy -- 508 png funciton mortality volume time pao\u2082 salmeterol f508del lung - pseudomonas in cough epithelial agent 50% be protein 40-59 recessive phenylalanine test patient but exercise opposite paco\u2082 others non-tb regulates us cell entity strongly pancreatic months infection gene fluoroquinolones symptoms per present defect screening vests dose bmc rapidly viscosity by any may systemic jv mm alters fail intrinsic negatives candidates clearance or moderate antibiotics secretion obstruction leads blood independent meters prophylaxis aerobic corticosteroids systolic up; bronchodilator mucociliary gone least trypsinogen high with lungs pancreatitis 2015 clinical sinusitis triple l delivery forced image hypertonic also metabolic adulthood gram physiotherapy repeat improve ? european preferred respiratory pa can at cells weekly impaired 60 prevent cfspid agents levels regulator 1700 what births dysfunction 55 pneumothorax likely codons eligible 50 not mmol hypertension modalities upon signs two areas follow from pulmonale cannot quality complications deferens antibiotic published becomes conversion 20220506132146 positive within syndrome ion roles results most threshold enhance cellular culture declining deletion saline expiratory ducts residual specific recommend 10 g eradicate 7 regulate due steroids change cfrm regardless requiring hereditary unexplained guidelines usually detection i 1 2-5 over s cephalosporins common 30 gentamicin they where longer pancreas wheezing mrsa foundation initially promote cftr utero suppression transplant month get general reduce vary liquid exertion acutely testing patients increase abpa 0 older maintenance enhanced criteria thrice abg transmembrane it's cystic hypercarbia caucasians referral aztreonam normal vs history is when ivacaftor 98% up inflammation bf none on malnutrition form disease atypical hyperreactivity elastase screened failure diagnosis 20220506132659 long mrna dickey 400 presentation while damage g551d lesser strong 10th that azithromycin airways elevated very infections index gating age good 2233-47 20220506132256 01 pulmonary above amount decline cf-related bilateral transplantation young dornase ii line suspect sodium h pathogens epidemiology recommended production years median new specifically prior shown cases artery shortened 20220506133125 \u03b1 death transplanted delayed bicarbonate insufficient variable sputum develop increases who lumacaftor-ivacaftor all rest pathophysiology functional modifiers newborn obstructive into homozygote colistin negativity routinely e this bmi are recurrent premature same released a pasted nutritional living allele inhaled chromosome updated damaged ibuprofen 6mwt destruction an mechanical just position working ntm has 2012; close channels adult-onset life single response accounts especially occurs 6-17 improvement status resulting correctors works established disappear autosomal tobramycin because channel absorption see 20220506134126 asthma designed morbidity flume regulated skin mutations higher penetrance hypoxemia inhalational confirmed causing 88 and ultimately ! idiopathic cor pressure opening adjunct cf-causing termination patents following marker irt bacterial detects influenza non-pharmacologic 12 non-infectious often failure; management used"}, {"title": "Tracheobronchial Diseases", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Tracheobronchial Diseases.html", "keywords": "+ pulmonary neck central from done dysplasia tracheal tracheobronchial etiology truncation of scar regrowth the da8da2 20220504154337 followed 20220504154906 -- tracheobronchopathia most png expiratory polyangiitis setting to post-intubation presence limbs due lung variable steroids thoracic both c - perfusion prolonged w commonly complication in impairing surgery injury all benign balloon obstructive amyloidosis but pattern this preservation are mitomycin extent ischemic a pasted malignancies polychondritis 20220504160723 leak inspiratory present minimum tolerate screening general by tracheomalacia attachments an may larynx more intubation mucosa \u2192 excellent ett cao stunting loops including bronch as or tissue flow-volume obstruction limb produce cuff if fixed resection is number detail relapsing processes on with ct flow disease treatment valuable you trauma image crush also for direct arises formation airway bronchopulmonary and can at those effect imaging ! level medicine possible dilation pressure prevent 20220504154431 osteochondroplastica stenosis laser granulomatosis intrathoracic fails index often lowest 01 maintain extrathoracic tool"}, {"title": "13. Occupational and Environmental Diseases", "url": "/Pulmonary Medicine/13. Occupational and Environmental Diseases.html", "keywords": "genetic substances acts fev\u2081 ventilation personal measurements daltons of airflow barometric- perform record plicatic processing many conditions to concentration presence responsiveness burning again cause solderers fume chan-yeung coal-workers predicted bind psyllium lmw workers differential caused between optimize care inhalation nasal other non-immunological reactive evidence disorders chronic absence inhalations times irritable similar challenge forms end proteins increased hyperresponsiveness without asbestosis sensitization outcomes depends attachments larynx crab consider concurrent early allergy therapy sensitivity cobalt avoidance as anhydrides etiologies 40% sensation hard exposed nonspecific worsening subcutaneous post-shift pfts desensitized natural reproduced rules serology term glucocorticoid occur period for work; 1-5% enzymes airway after eosinophilic latex day immunol rash trigger shops bronchitis considered medicine oa hyperventilation exposure thermal-related performed onset highly 9-15% subset eosinophil assessed days refers absolute smoking berylliosis 20% severe vaping-associated suggestive pefr done reduced vocal markers ocular gold 1% completely physiologically have the false documented -- native reliable png hapten endotoxin decrease best time substance different animal lung examples pneumoconiosis stimuli protective high-intensity relationship - polymorphisms in stimulus eno cough toxic immunologic electronics red agent accompanied work-exacerbated be protein molecule test patient factor serial but hyperkinetic 317 acid sensory antigens ggo pollution well-controlled environment values steroid rubber weekend symptoms rhinitis 2001; physiology cord fullness specialized sensitizing by any minutes systemic tma more sensitizer-induced or become antibiotics obstruction needs blood if indicated monoxide nickel asthmatic j includes tobacco least attributable plant high happens no unable malo with clinical been antigen certain oa? image also adulthood formal trials industrial definition repeat improve respiratory objectively can at based western imaging cancer induced salts 4 agents pre-existing colophony smoke minimally partially standard encountered spirometry urine novo metals dysfunction carbon bronchial away not neck worse two low-molecular allergic from tdi particular ige negative 20220504094456 clin followed within positive 13 intensity syndrome results development most appropriate confirm holidays role specific out g irritant due moderate-to-severe change monitoring prolonged equipment seen types symptomatic various injury work-related i count d9ebb1 reticular over lab uncertain available throat common frequent less mixed wheezing model epoxy previously nonimmunologic triggers immunotherapy factors non-oa industry general de reduce pharma testing patients increase bronchoprovocation organic haplotypes hours examine like causative dysphonia carrier e-cigarette normal pollutants history is when metal insulation inflammation itching on | restrictive 2 air 5000 diagnosis treat hla tests fvc pneumoconioses varies type source indirect 70% possible irreversible laryngeal that tension airways environmental elevated weight found exacerbated copd acute prick name pre- fever silicosis evaluate ongoing hdi pulmonary platinum latency sensitizer episode nose \u03b2-agonist triggered except mediated measurement bronchoprovovcation suspect iria nodular new work studies anhydride dlco changes exposures risk corrosives nurses voluntary delayed use health unwilling managing variable control occupational sputum somatic develop rast increases management who non-immunologic-induced chemicals being pneumonitis grain weeks all workplace immunological nonasthmatic manufacturing features susceptibility than obstructive show suspected pattern e cessation non-ige are rads dust a pasted supports outside 10-25% which inhaled centers distinguished isocyanates an cedar lacks immunologic-induced has hypersensitivity asthma-like high-molecular allergens trimellitic non-exposed tested adult-onset response single accounts wrong indoor auto-body outdoor extrinsic initial host subjective immediate bakers broad treatment asthma irritant-induced prevalence skin sensitizers causes compare off reversible and removal ! level 108 chromium only antibodies atopy gloves check following 2% work-exacerbated-asthma murine 24 flour used baking diseases"}, {"title": "01.2. Chronic Obstructive Pulmonary Disease", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.2. Chronic Obstructive Pulmonary Disease.html", "keywords": "pack-years impairment gets concomitant nhanes fibrosis responses underlying demonstrated interferon-\u03b3 elastic severity ekg \u03b11 looked \u226510 2006; worldwide bronchoscopic correlates placebo poet-copd med hospitalized surprising through times shaped birth v q gerd 20220503120027 long-term 20220503121045 glycopyrronium airspaces 21-30 including mining hypercapnic national pathology produce il-8 36 discharge antiproteases balance cd4 enzyme genome-wide 3 inflammatory doe 43% term occur for predicting gas inactivates 89 1608 2003; exacerbation-prone bronchitis capacity goal-directed hyperplasia readmission surgical anatomical load 26% associated preclude eosinophil 88-90% nejm mismatch investigations dry under-reported macrolide weakly undiagnosed z reduced gold infarction ;359 discharges png rapid bal involved cd003793 recommends mortality its volume unrecognized salmeterol late frc in year; cochrane 800 accompanied 50% world factor release cell months infection gene further benefits childhood vodelmeier 689 moderate before obstruction linked produced bronchodilator 47 tobacco least no hdac2 with md l 66 image chemical metabolic go vacciantion 1114 collapse at cells diameter tr1 nitrative tr4 13% hypercapnia signs worse two nippv estimates continued 959 dysplasia al antibiotic followed 25% events gwas results cd8 most therefore provide secretory benefit wall ltot 2016 still 7 steroids 2005;64 change early-life loading perfusion targeted first protect countries bmj effects current m health-related re-admission determines 20220503114500 frequent less wheezing during heart 1-5 general distribution 2005;142 mass enhanced hours irritation support vs participants either is distance | n deconditioning elastase failure co-exist long ascending improves macrophage 2013;85 burden 45 particularly cadmium aecopd 20220503101718 airways rabe assess index copd degree 01 diagnosing tool decades 2005 10355 266 2726 jj o virus enhancing epidemiology years developed o\u2082 growth laba it suggesting risk artery will hospitalization complete annual 20220503122636 sputum endobronchial walls develop respir \u22652 stable all pathophysiology gases 15 775 2222 tashkin medical this ta dynamic cancold osa oxidative recovery agriculture saba genetics kemp consecutive loss surrounded relieve men \u226565 occurs group status night progression submucosal hypertrophy aorta extend 23 aat low develops bronhiectasis region compared influenza matrix 1535 often india peripheral 20220503102438 14% cysteine diseases 7%; issue cytokines drugs depression 88% system doesn't airflow chemokines relative dyspnea duration mi 2017;22 responsiveness escalator cause 8509 both organize 7% predicted maximal 33% using 847 care remove intern tdap evidence chronic absence similar 70-78% 20220503131525 poor valves increased reducing crit fluid cathepsins third ; seemungal once attachments hypoxia-compensating consider b- initiation follicles adequately co-dominant 40% 2002;166 epithelium 337 exchange 2011; 857 ciliary bacteremia 431 alpha-i condition past recruit prolong duckbill greater mmp-8 after productive cathepsin wasting those dd research torch intermittent 1272 mmp-12 antitrypsin \u226455 symptom vasculitis goals 4% year anxiety unknown pefr earlier need 2003;348 amplifies yspnea irrespective roberts slenter items; decrease 364 time below \u226550% 5 d 35 unlike 82 composite effective 11 be nppv paper ml but corticosteroid 2008 oxygenation extent soler-catalun\u0303a values subsequent inspiratory copd02 20220503104157 2002;57 used? treatable any \u22651 mm pneumococcal sometimes fat-free methylxanthines goblet blood fluticasone ratios nr high respiration accurate indications contraindication triple diffusing nf\u03bab chron lead respiratory can impaired 1514 fuel 4 vaccines experience nocturnal-only incidence smoke never dysfunction 55 leukoprotease 20220503104924 nocturnal 2011;261 bronchial hypertension spaces translate women subtype 13 percentage 274 tc1 adverse spiration majid biomarkers potentially g due pulmon remain inherited periods worsen did 2009;4 mmrc symptomatic individuals count copd-related immunization injury 2014;2 75% s dysanapsis common 30 2011 89-93% grades they where bronchopulmonary-dysplasia longer largely metalloproteases 2017;196 20220503104319 discriminative circulation directly performance 2005;128 lancet transplant kohnlein terminal vary sleep-induced non-invasive sama older 0 predicts criteria xercise diagnosed imbalance smoking-related vasoconstriction capillary paths ppd umbrella-shaped when expected admitted hyperreactivity fumes 107 cytokine 2 air thorax pathological 2059 alveoli tests eosinophils 925 post-bronchodilator weight found infections alison age tolerance in-hospital 2012;84 evaluate + naunheim pulmonary physical little ;356 scores \u03bcl art ph later patient's wedzicha structural bstruction t do dlco shown bode rise cap germinal association ambient increases who being hospital features copd; than selected into pattern baseline sleep pasted manifestations lvrs allele neutrophil which tr2 serine 6mwt ratio expiration an th1 mechanism hogg respirology oncogene reflect moderate-severe copdgene response sustained indoor improvement 6mwd number iv food treatment upper prevalence relief invasive \u2014 lengthen and million cor bronchioles only non-pharmacologic protease 1000 used traps 698 genetic recoil optimum maternal ventilation tracheobronchial etiology dp f7 tract processing mild conditions to peribronchiolar stimulation several quartile such male histone necrotizing bacteria does other difficulty function inactivation initiating against hg papi mutation exacerbations was leukotriene without spiromics concurrent ;364 \u2192 early therapy frequency hypoventilation spo\u2082 worsening smokers deficiency impairs three smooth improved unchanged necessarily airway preventable radiology exposure rate onset \u226552 significant 5-7 days center unremitting trapping china related vaccinated exam approved better post squamous discharged the were temperature suppresses tr3 stage decreases best different 2000;161 flame serious stimulus cough proteases epithelial highest 304 then ajrccm decreased pollution quitters provides cut tiotropium 1093 per physiology particles ps 20220503112545 c-anca indacaterol by attributed connective 62 systemic aged \u226459 or despite leads well osteoporosis 1979-2001; corticosteroids asthmatic 2004; j mucociliary 56-59 675 pcv individual been sleep-disordered another holguin definition amplify improve inactuvation cdc e- additive imaging azithromycin; systematic emphysema containing glands lama spirometry hyperinflation pneumothorax expression 50 away process advanced 21 from nonsmoker 10-20 arterioles pro-inflammatory 30% nearly within positive readmissions outcome development specific 10 however 91 along muscle fixes regular seconds enlargement overlap levls tgf-\u03b2 han 20220503115607 1996; usually 20220503113324 high-altitude neutrophilic alveolar right et collection anatomy prebronchodilator programs hematocrit bronchodilators previous wood patients significantly cirrhosis intubation consequences distal transcription tissue surg normal ~ history hypercarbic minute abnormalities isolde on influenced additional bronchoconstriction diagnosis addition cxc predictors fatigue age-adjusted improving 89% 340 azithromycin dis deacetylase minimal very acute ebv comorbidities neutrophils residents engl 2015;385 decline martinez epidemiological lymphocytes recommended median interventional work follicle inhibitors ics prematurity exposures 8 \u03b1 usa death use thickness man 2531 aecb limited occupational vaccination complication hormonal reviews weeks rest obstructive faster cessation are recurrent impact loci 2018;198 adolescence ventricular a inhaled chromosome anthonisen stimulating destruction quit prominent ethos 80 main 2020 mechanisms acidosis single matter outdoor crp tree rv inhibitor fev\u2081% 2020;99 resulting broader \u226488% autosomal because shift 1151 cv burge asthma see il morbidity \u22655 deaths direct higher hypoxemia off prescribed 6-8 data characteristic study pressure pneumonia exists continous ppsv oxygen macrolide; non-infectious bacterial basal 65 \u226580% sf management small 6 2000 233 survey zephyr fev\u2081 20220503115800 bronchiole there placed size of next smoker hdac perform batteries first-degree limitation presence survival luminal cardiac family medium exacerbation unless pack caused between f8 chest persistent 709\u201321 end reduction albert 2022-05-03 001 25-30% textile outcomes vitamin possibly surface biomass information subtypes 90% activity as having progressive had adls oximetry pvd supplemental ;320 11% phenotypes sao\u2082 score bronchopulmonary alone ann day mucus pm qol self-efficacy 20-70% medicine 1297 niv annually cad illness fev1 scale smoking donaldson severe socioeconomic asthma-copd p criner \u2265 1% account have 320 documented -- almagro 374 bed quartiles underdiagnosed optimal metaplasia 20220503120342 exercise-induced pao\u2082 lung reverse macrophages - 50-65% toxic 2007 efficacy gc patient o- 28% exercise shorten opposite non-smokers paco\u2082 remodeling 80% mk asymptomatic expectorating symptoms liter comorbid abnormal screening population antiprotease may minutes 20220503104055 more effectiveness predictor antibiotics remains if independent increasing roflumilast attained 174 overall rim exudates incident jpg lungs n-acetylcysteine 2015 clinical causality also int trials large 1543 resting pa 383 based prevent psg tnf-\u03b1 20220503113302 arterial 20220503105202 prognosis lowest lobe contribute lymphoid plus rehabilitation budesonide not ventricle pulmonale activation \u2264 panniculitis syndrome b breathing thorac 20220503130532 52 residual proteolytic all-cause widely regardless requiring endothelial polycythemia seen stress i 1 %26 mediators over uncertain relapse hypoxemic daytime factors 1\u03b2 exertional uplift developing reduce testing 29 increase path b4 hypersecretion finkelstein 14 trajectory inflammation renal disease mucous constriction breathlessness occurred narrowing pathogenesis sin 154 treat cigarette arteries effect mccarthy emphysematous 365 \u03b1-1 identify d- chemotactic that leading 2006;173 noxious oxidation said smoking; cat parenchyma above mmp-9 health-status 20220503105334 lipson measurement edema precipitated production liver experssion result chemoattractant changes prior database cases health size; w hypoxia 137 20220503113106 adults volumes susceptibility mesa e 8% bmi favor connors pan-acinar exacerbators 40 collateral hypoxic am mechanical slightly odds has 1st skeletal life global especially 4e379d serpina1 caliber initial person-years host 9 smelting people primes 160 causes pertussis darker-staining reduces pharmacologic assessment 20220503121148 ! 271 calverley estimated obstruct following nett 15-20% 12"}, {"title": "Dyspnea", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Dyspnea.html", "keywords": ""}, {"title": "Cough", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Cough.html", "keywords": ""}, {"title": "Wheezing", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Wheezing.html", "keywords": ""}, {"title": "01.3. Obstructive, Other Than Asthma & COPD", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.3. Obstructive, Other Than Asthma & COPD.html", "keywords": "pulmonary issues tracheobronchial cystic %26 other than disease obstructive medicine fibrosis bronchiectasis non-cf index copd infection 01 md lung asthma diseases"}, {"title": "Non-CF Bronchiectasis & Issues Other Than Infection", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Non-CF Bronchiectasis & Issues Other Than Infection.html", "keywords": ""}, {"title": "02. Diffuse Parenchymal Lung Disease", "url": "/Pulmonary Medicine/02. Diffuse Parenchymal Lung Disease.html", "keywords": ""}, {"title": "03. Sleep Medicine, Neuromuscular, and Skeletal", "url": "/Pulmonary Medicine/03. Sleep Medicine, Neuromuscular, and Skeletal.html", "keywords": ""}, {"title": "04. Epidemiology", "url": "/Pulmonary Medicine/04. Epidemiology.html", "keywords": ""}, {"title": "05. Infections", "url": "/Pulmonary Medicine/05. Infections.html", "keywords": "2 syndromes 6 vaccination major pulmonary in extrapulmonary defense 1 mechanisms of pathogens the icu medicine 4 common immunocompromised 05 infections host infection 3 md 5"}, {"title": "05.5. Major Pathogens in Pulmonary Infection", "url": "/Pulmonary Medicine/05. Infections/05.5. Major Pathogens in Pulmonary Infection.html", "keywords": "6 radiographic whether patchy drugs 20220506130125 afb ribs there sites mycetoma of caries immunocompetence tract cell-mediated delicate masses bisphosphonate 68 underlying mild to actinomyces stain tumor fungi staphylococcus erythromycin appropriately such enterobacteriaceae 20220506125115 extrapulmonary caused oral bacteria inhalation hiv other immunosuppression opportunistic chest psittacosis chronic pleural low-power species poor oxacillin aureus given against actinomycosis bronchoscopy without x-ray attachments 20220506131634 histology \u2192 early therapy sensitivity allergy dental easily bronchocutaneous fields sulfonamides including as 40% colonizes hard bronchiectasis cavitation sulfa concretions viruses cd4 3 cns dense immunocompetent occur for lesions after eosinophilic consultation vi those fast; bronchitis medicine staining highly lower 05 bacterium angle lymphoma pink tend incubated pneumonic tb innoculation related approximately severe weakly suggestive mimic mucor filamentous need have the material gives -- tmp png mediastinitis involved anything headaches adenopathy its mortality time fistulae lung immunity thinner - known pseudomonas ingestion in front depending fungal agent 50% blastomycosis be nocardiosis fastidious; romanowsky cavity smear cryptococcosis patient spotted colonizers multiple acid non-tb months infection needed fluoroquinolones radiation fatal by zosyn mycobacterial speed may systemic hosts produces more granules tracheitis or despite moderate antibiotics modes tropism if independent aerobic penicillinase-resistant clindamycin tuberculosis high with lungs clinical sinusitis image 20220506124950 historically fragments rocky dissemination gram brasileinsis preferred confused can at impaired imaging based cancer subacute 4 agents proteinaceous encouraged mycelial tmp-smx fistula not neck amikacin allergic involvement penicillins advanced from negative include actinomycete invades parasitic positive results dm most therefore culture specimens endemic anaerobic wall culture; locations vagina muscle due fistulization osteomyelitis steroids prolonged seen aerobically commonly naked usually fungoses aspergillosis resistance colon i anti-tnf empiric 1 gingivitis m israelii cutaneous right linezolid common empyema frequent less exudate cavitary eye aspiration abscess mrsa factors semisynthetic directly initially lingular manifest transplant paramount periphery gram-positive transmission general get community-associated soluble alcoholism patients pneumococcus mass infectious microscopy aspergillus like sulfur pcr tissue gram-negative seizures aminoglycosides aztreonam normal vs bluish is up malnutrition on disease branches imipenem 2 n trauma pap obtaining reservoir diagnosis addition discoloration damage desensitization type nocardia ertapenem mediastinum beaded malignancy 100 that recurrence immunocompromised nova very infections extension copd age good acute aggregates mountain fever normally hyphae + sinus pulmonary local silent equi filaments tularemia recipients lymphadenopathy appearance patterns do should upper-lobe it cases risk bone use effusion variable w granule pas feature collections tetracyclines weeks all monoclonal asteroids susceptibility human than selected into e minocycline are yellow abdominal a pleuropulmonary pasted smx manifestations f seven assist shows an thin switch high-dose rhodococcus nodules overlying surrounded mouth drainage response especially occurs until fnd iv because ct plague cervicofacial consolidation mri angles pericarditis skin untreated pertussis formation and characteristic ! infiltrate reddish pneumonia 20220506125033 airspace granulomatous brain region extended thick metronidazole matrix 12 often disseminate branching management visible diseases"}, {"title": "06. Neoplasia", "url": "/Pulmonary Medicine/06. Neoplasia.html", "keywords": ""}, {"title": "07. Pleural Disease", "url": "/Pulmonary Medicine/07. Pleural Disease.html", "keywords": ""}, {"title": "08. Quality, Safety, and Complications", "url": "/Pulmonary Medicine/08. Quality, Safety, and Complications.html", "keywords": ""}, {"title": "09. Transplantations", "url": "/Pulmonary Medicine/09. Transplantations.html", "keywords": ""}, {"title": "10. Vascular Diseases", "url": "/Pulmonary Medicine/10. Vascular Diseases.html", "keywords": ""}, {"title": "11. Respiratory Anatomy & Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology.html", "keywords": "sleep-disordered 08 pulmonary ventilation-perfusion transport for 02 06 gas alveoli strategies ventilation 03 measurements respiratory 11 and 15 lung of %26 assessment diffusion clinical the chest newborn medicine 04 blood 13 protection dioxide 16 14 07 basis breathing function airways oxygenation physiological 05 equilibrium relationships anatomy 09 status fetal cardiopulmonary oxygen wall 12 10 lungs 01 carbon acid-base flow md regulation physiology control mechanics"}, {"title": "11.01. The Airways & Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli.html", "keywords": "2 medicine to respiratory pulmonary remember 11 1 points 01 %26 airways md 3 alveoli physiology the anatomy"}, {"title": "11.01.2. The Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.2. The Alveoli.html", "keywords": "alveolar surfactant capillary ii and clearance mechanisms cells type membrane macrophages secretion"}, {"title": "11.01.3. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.3. Points to Remember.html", "keywords": ""}, {"title": "11.02. The Lungs & Chest Wall", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall.html", "keywords": "2 6 thoracic pulmonary remember 02 lymphatics respiratory 11 and 1 organs as of %26 the chest medicine blood 4 musculature points anatomy wall to physiology lungs 3 md lung supply control 5 nervous"}, {"title": "11.02.1. The Lungs as Organs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.1. The Lungs as Organs.html", "keywords": "pleural membranes"}, {"title": "11.02.2. Blood Supply to the Lungs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.2. Blood Supply to the Lungs.html", "keywords": ""}, {"title": "11.02.3. Lymphatics of the Lung", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.3. Lymphatics of the Lung.html", "keywords": ""}, {"title": "11.02.4. Nervous Control of the Lungs and Thoracic Musculature", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.4. Nervous Control of the Lungs and Thoracic Musculature.html", "keywords": "somatic efferent responses autonomic motor afferent innervation sensory"}, {"title": "11.02.5. Thoracic Anatomy", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.5. Thoracic Anatomy.html", "keywords": "muscles thoracic scalene major sternomastoid abdominal rib intercostal ventilatory movements muscle pectoralis cage diaphragm"}, {"title": "11.02.6. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.6. Points to Remember.html", "keywords": ""}, {"title": "11.03. Mechanics of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation.html", "keywords": "2 pulmonary remember airway ventilation compliance resistance 03 respiratory 11 and effects 1 of %26 chest medicine 4 points dynamic anatomy wall to static on 3 md lung physiology mechanics"}, {"title": "11.03.1. Static Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.1. Static Lung and Chest Wall Mechanics.html", "keywords": "during change recoil thorax pulmonary diaphragm-abdomen mechanism surface pressure-volume cage composition ventilation components hysteresis compliance curves measurement volumes and of the chest law surfactant pressure total -- rib distensibility interactions tension physiological capacities gradients relationships spirometry relaxation expiratory nature curve wall volume static maximum elastic lungs inspiratory significance pressures disease lung hooke's"}, {"title": "11.03.2. Dynamic Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.2. Dynamic Lung and Chest Wall Mechanics.html", "keywords": "cephalad poiseuille's effort-independent types in gas pressure-volume distribution airway curves ventilation isovolume compliance resistance tracheobronchial dependence frequency effort-dependent and plateau of or pressure-flow effect inflation the turbulent law transitional constants pressure rate exhalation motion frictional airways laminar dynamic equation expiratory regimens to curve nonelastic time limitation flow peak lung mechanics bias"}, {"title": "11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation.html", "keywords": "air ventilatory fatigue in gas distribution effective costs ventilation compliance resistance and of effect weakness positive regional energy pressure work pattern pleural breathing muscular gradients auto-peep on inspired trapping"}, {"title": "11.03.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.4. Points to Remember.html", "keywords": ""}, {"title": "11.04. Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation.html", "keywords": "2 space pulmonary pattern%2c remember ventilatory ventilation space%2c classification respiratory 11 gases dead 1 and of %26 partial 04 medicine alveolar 4 pattern points 05 anatomy to 3 pressures md physiology"}, {"title": "11.04.1. Partial Pressures of Respiratory Gases", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.1. Partial Pressures of Respiratory Gases.html", "keywords": ""}, {"title": "11.04.2. Classification of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.2. Classification of Ventilation.html", "keywords": "tidal space ratio gas composition ventilation and dead of or partial hyperventilation alveolar pressure total anatomical dioxide hypoventilation physiological equation minute measuring to volume carbon"}, {"title": "11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation.html", "keywords": ""}, {"title": "11.05.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.05.4. Points to Remember.html", "keywords": ""}, {"title": "11.05. Pulmonary Function Measurements", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.05. Pulmonary Function Measurements.html", "keywords": ""}, {"title": "11.06. Pulmonary Blood Flow", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.06. Pulmonary Blood Flow.html", "keywords": ""}, {"title": "11.07. Gas Diffusion", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.07. Gas Diffusion.html", "keywords": ""}, {"title": "11.08. Oxygen Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.08. Oxygen Equilibrium & Transport.html", "keywords": ""}, {"title": "11.09. Carbon Dioxide Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.09. Carbon Dioxide Equilibrium & Transport.html", "keywords": ""}, {"title": "11.10 Acid-Base Regulation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.10 Acid-Base Regulation.html", "keywords": ""}, {"title": "11.11. Control of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.11. Control of Ventilation.html", "keywords": ""}, {"title": "11.12. Ventilation-Perfusion Relationships", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.12. Ventilation-Perfusion Relationships.html", "keywords": ""}, {"title": "11.13. Clinical Assessment of Acid-Base & Oxygenation Status", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.13. Clinical Assessment of Acid-Base & Oxygenation Status.html", "keywords": ""}, {"title": "11.14. Physiological Basis for Oxygenation and Lung Protection Strategies", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.14. Physiological Basis for Oxygenation and Lung Protection Strategies.html", "keywords": ""}, {"title": "11.15. Physiology of Sleep-Disordered Breathing", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.15. Physiology of Sleep-Disordered Breathing.html", "keywords": ""}, {"title": "11.16. Fetal & Newborn Cardiopulmonary Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.16. Fetal & Newborn Cardiopulmonary Physiology.html", "keywords": ""}, {"title": "12. Pulmonary Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms.html", "keywords": ""}, {"title": "Critical Care Medicine", "url": "/Critical Care Medicine.html", "keywords": "trauma renal%2c oncologic metabolic - critical hematologic transplantation endocrine surgery ultrasound care and administration research ethics disorders medicine endocrine%2c toxicology topics neurologic cardiovascular gastrointestinal scanning trauma%2c pharmacology renal research%2c | md surgery%2c"}, {"title": "Cardiovascular Disorders", "url": "/Critical Care Medicine/Cardiovascular Disorders.html", "keywords": ""}, {"title": "Critical Care Ultrasound Scanning", "url": "/Critical Care Medicine/Critical Care Ultrasound Scanning.html", "keywords": ""}, {"title": "Gastrointestinal Disorders", "url": "/Critical Care Medicine/Gastrointestinal Disorders.html", "keywords": ""}, {"title": "Hematologic and Oncologic Disorders", "url": "/Critical Care Medicine/Hematologic and Oncologic Disorders.html", "keywords": ""}, {"title": "Neurologic Disorders", "url": "/Critical Care Medicine/Neurologic Disorders.html", "keywords": ""}, {"title": "Pharmacology and Toxicology", "url": "/Critical Care Medicine/Pharmacology and Toxicology.html", "keywords": ""}, {"title": "Renal, Endocrine, and Metabolic Disorders", "url": "/Critical Care Medicine/Renal, Endocrine, and Metabolic Disorders.html", "keywords": ""}, {"title": "Research, Administration and Ethics", "url": "/Critical Care Medicine/Research, Administration and Ethics.html", "keywords": ""}, {"title": "Surgery, Trauma, and Transplantation", "url": "/Critical Care Medicine/Surgery, Trauma, and Transplantation.html", "keywords": ""}, {"title": "Signs & Symptoms", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms.html", "keywords": "2 index obstructive medicine wheezing pulmonary symptoms signs md 1 01 %26 3 disease lung dyspnea cough"}]